OPALIN | Oligodendrocytic myelin paranodal and inner loop protein | Predicted membrane proteins
| | | | | Tissue enriched |
GFAP | Glial fibrillary acidic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
OLIG2 | Oligodendrocyte lineage transcription factor 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
SLC17A7 | Solute carrier family 17 (vesicular glutamate transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CREG2 | Cellular repressor of E1A-stimulated genes 2 | Predicted secreted proteins
| | | | | Tissue enriched |
SNCB | Synuclein, beta | | | | | | Tissue enriched |
MOG | Myelin oligodendrocyte glycoprotein | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CACNG8 | Calcium channel, voltage-dependent, gamma subunit 8 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ELAVL3 | ELAV like neuron-specific RNA binding protein 3 | | | | | | Tissue enriched |
GABRA1 | Gamma-aminobutyric acid (GABA) A receptor, alpha 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
AMER2 | APC membrane recruitment protein 2 | | | | | | Tissue enriched |
CAMKV | CaM kinase-like vesicle-associated | Enzymes
| | | | | Tissue enriched |
PLP1 | Proteolipid protein 1 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ERMN | Ermin, ERM-like protein | Cytoskeleton related proteins
| | | | | Tissue enriched |
SLC32A1 | Solute carrier family 32 (GABA vesicular transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Transcription factors
| | | | | Tissue enriched |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
GAP43 | Growth associated protein 43 | Plasma proteins Transporters
| | | | | Tissue enriched |
GPM6B | Glycoprotein M6B | Predicted membrane proteins
| | | | | Tissue enriched |
TNR | Tenascin R | Predicted secreted proteins
| | | | | Tissue enriched |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | | | | | | Tissue enriched |
SYN1 | Synapsin I | Disease related genes Plasma proteins
| | | | | Tissue enriched |
HPCA | Hippocalcin | Plasma proteins
| | | | | Tissue enriched |
MOBP | Myelin-associated oligodendrocyte basic protein | | | | | | Tissue enriched |
PACSIN1 | Protein kinase C and casein kinase substrate in neurons 1 | Plasma proteins
| | | | | Tissue enriched |
SEPT3 | Septin 3 | | | | | | Tissue enriched |
RTN1 | Reticulon 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SLC17A6 | Solute carrier family 17 (vesicular glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SNAP25 | Synaptosomal-associated protein, 25kDa | FDA approved drug targets Transporters
| | | | | Tissue enriched |
MBP | Myelin basic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CNTNAP4 | Contactin associated protein-like 4 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC1A2 | Solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GABBR2 | Gamma-aminobutyric acid (GABA) B receptor, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enriched |
HAPLN2 | Hyaluronan and proteoglycan link protein 2 | Predicted secreted proteins
| | | | | Tissue enriched |
AK5 | Adenylate kinase 5 | Enzymes
| | | | | Tissue enriched |
FABP7 | Fatty acid binding protein 7, brain | | | | | | Tissue enriched |
FAM181B | Family with sequence similarity 181, member B | | | | | | Tissue enriched |
GPR62 | G protein-coupled receptor 62 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
KCNC1 | Potassium voltage-gated channel, Shaw-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
RPH3A | Rabphilin 3A homolog (mouse) | | | | | | Tissue enriched |
SYT11 | Synaptotagmin XI | | | | | | Tissue enriched |
CADM2 | Cell adhesion molecule 2 | Predicted membrane proteins
| | | | | Tissue enriched |
DSCAM | Down syndrome cell adhesion molecule | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes
| | | | | Tissue enriched |
CEND1 | Cell cycle exit and neuronal differentiation 1 | Predicted membrane proteins
| | | | | Tissue enriched |